Pharmacokinetics and Safety of a Bilastine Once-Daily, Preservative-Free, Ophthalmic Formulation
Adv Ther. 2021 Jul;38(7):4070-4081. doi: 10.1007/s12325-021-01801-y. Epub 2021 Jun 12. ABSTRACT INTRODUCTION: Bilastine is a second-generation H1 antihistamine indicated for the symptomatic treatment of allergic rhinoconjunctivitis and urticaria. On the basis of the demonstrated efficacy and safety of the oral formulation, a new ophthalmic formulation of bilastine was recently developed. Previous preclinical studies had indicated…
